Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Merck to release hep C data
Yahoo/Investors Business Daily
Wed, 10/8/14 - 08:32 pm
Merck
hepatitis C
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Gilead Sciences
hepatitis C
Sovaldi
Merck
AbbVie
Idenix
Bristol-Myers Squibb
Achillion
Merck Gardasil follow-up could block 90% of cervical cancers--if uptake improves, that is
Fierce Vaccines
Fri, 10/3/14 - 09:58 am
Merck
Gardasil
HPV
cervical cancer
vaccines
9-valent HPV vaccine
Esperion shares rally on cholesterol drug study results
Marketwatch
Wed, 10/1/14 - 06:41 pm
Esperion Therapeutics
ETC-1002
Merck
Zetia
Bayer launches US$7bn six-tranche acquisition bond
Yahoo/Reuters
Wed, 10/1/14 - 06:27 pm
Bayer
M&A
Merck
consumer health
ESMO: The latest skinny on drugs from Pfizer, Novartis, GSK, Merck, BMS
Fierce Pharma
Tue, 09/30/14 - 10:08 am
ESMO
Pfizer
Novartis
GSK
Merck
Bristol-Myers Squibb
Pharma Events To Watch Out For This Week
Bidness Etc.
Mon, 09/29/14 - 01:15 pm
Salix
Progenics
Relistor
AASLD
Merck
Gilead Sciences
AbbVie
Intercept Pharma
AstraZeneca Might Outperform Merck, Bristol-Myers In Cancer Therapy Market
Bidness Etc.
Mon, 09/29/14 - 10:31 am
Merck
Bristol-Myers Squibb
AstraZeneca
MEDI4736
cancer immunotherapy
Merck immunotherapy drug shows promise in bladder cancer
Yahoo/Reuters
Mon, 09/29/14 - 07:52 am
Merck
bladder cancer
immunotherapy
Keytruda
MSD Announces First Presentation of Data on the Investigational Use of Pembrolizumab in Patients with Advanced Gastric Cancer at
Yahoo/BusinessWire
Sun, 09/28/14 - 10:10 am
Merck
Pembrolizumab
gastric cancer
Keytruda
Merck Buys Sigma-Aldrich for $17 billion
Digital Journal
Sat, 09/27/14 - 10:01 am
Merck
Sigma-Aldrich
M&A
Key Pharma Events For the Week Ahead
Bidness Etc.
Mon, 09/22/14 - 03:47 pm
Celgene
Otezla
CHMP
Gilead Sciences
Roche
Novartis
Merck
Eli Lilly
JNJ
GSK
Sanofi
Teva
Merck's weekly diabetes drug stacks up to blockbuster Januvia in Phase III
Fierce Biotech
Thu, 09/18/14 - 09:24 am
Merck
diabetes
Januvia
omarigliptin
MK-3102
Merck licenses experimental psoriasis drug to India's Sun Pharma
Yahoo/Reuters
Wed, 09/17/14 - 04:35 pm
Merck
Sun Pharma
psoriasis
tildrakizumab
India
BMS striving to push Opdivo past Keytruda
Medical Marketing and Media
Wed, 09/17/14 - 09:52 am
Bristol-Myers Squibb
Merck
Opdivo
Keytruda
anti-PD-1 immunotherapy
Side effect fears weigh on Merck osteoporosis drug
Pharmaphorum
Tue, 09/16/14 - 10:25 am
Merck
osteoporosis
Odanacatib
Long-delayed Merck osteoporosis drug meets goal in study
Yahoo/Reuters
Mon, 09/15/14 - 04:31 pm
Merck
osteoporosis
Odanacatib
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
24/7 Wall St
Mon, 09/15/14 - 11:36 am
hepatitis C
Gilead Sciences
AbbVie
Achillion
Merck
Sovaldi
Idenix
Big Pharma: $100 Billion In Future Sales Expected
Bidness Etc.
Mon, 09/15/14 - 10:10 am
Bristol-Myers Squibb
Merck
GSK
Novo Nordisk
Sanofi
Novartis
Pfizer
Biogen Idec
Roche
Merck's Mantra On Focus Precludes An Inversion Strategy
Forbes
Mon, 09/15/14 - 08:47 am
Merck
tax inversions
Keytruda
melanoma
Pages
« first
‹ previous
…
101
102
103
104
105
106
107
108
109
…
next ›
last »